Orthobiologics

Studies suggest that a single injection of Mesenchymal Precursor Cells resulted in meaningful improvements in chronic low back pain and function...

SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration....

TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second...

Interim results from study of BonyPid®-1000 bone substitute in the treatment of open tibial fractures indicate that the product met performance and...

Bone Therapeutics completed recruitment of 16 patients in the Phase I/IIA delayed-union fracture study of ALLOB® allogeneic cell therapy product....

Studies of BonAlive® indicate that the naturally-antibacterial bioactive glass yields excellent results in the treatment of osteomyelitis, without the use of...

Amend Surgical received FDA 510(k) clearance to market NanoFUSE® BA as a bone graft extender for spine and orthopaedic applications....

Synergy Biomedical received approval under the CE Mark for BIOSPHERE synthetic bone graft putty....

Paragon 28 launched PRESERVE™ HammerGraft™, aseptically-processed allograft implants for the treatment of hammertoe deformity....

Tissue Regenix plans a 2018 launch for dCELL® decellularization technology in the U.S. for orthopaedic applications, initially addressing ACL repair. ...